NEW YORK, NY / ACCESSWIRE / September 20, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
OTLY Shareholders Click Here: https://www.zlk.com/pslra-1/oatly-group-ab-loss-submission-form?prid=19709&wire=1
ARDX Shareholders Click Here: https://www.zlk.com/pslra-1/ardelyx-inc-loss-submission-form?prid=19709&wire=1
ATVI Shareholders Click Here: https://www.zlk.com/pslra-1/activision-blizzard-inc-loss-submission-form?prid=19709&wire=1
* ADDITIONAL INFORMATION BELOW *
Oatly Group AB (NASDAQ:OTLY)
OTLY Lawsuit on behalf of: investors who purchased May 20, 2021 - July 15, 2021
Lead Plaintiff Deadline: September 24, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/oatly-group-ab-loss-submission-form?prid=19709&wire=1
According to the filed complaint, during the class period, Oatly Group AB made materially false and/or misleading statements and/or failed to disclose that: (a) Oatly overinflated its gross margins, revenue, capital expenditure, and market share financial metrics; (b) the Company overstated its sustainability practices and impact; (c) the Company exaggerated its growth in China; and (c) as a result of the foregoing, Oatly's statements about its operations, business, and prospects were misleading during the Class Period.
Ardelyx, Inc. (NASDAQ:ARDX)
ARDX Lawsuit on behalf of: investors who purchased August 6, 2020 - July 19, 2021
Lead Plaintiff Deadline: September 28, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/ardelyx-inc-loss-submission-form?prid=19709&wire=1
According to the filed complaint, during the class period, Ardelyx, Inc. made materially false and/or misleading statements and/or failed to disclose that: 1) the Company overstated the likelihood that tenapanor would be approved by the Food and Drug Administration ("FDA"); and 2) Defendants possessed, were in control over, and as a result, knew that the data submitted to support the New Drug Application was insufficient in that it showed a lack of clinical relevance of the drug's treatment effect, making it foreseeably likely that the FDA would not approve the drug.
Activision Blizzard, Inc. (NASDAQ:ATVI)
ATVI Lawsuit on behalf of: investors who purchased August 4, 2016 - July 27, 2021
Lead Plaintiff Deadline: October 4, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/activision-blizzard-inc-loss-submission-form?prid=19709&wire=1
According to the filed complaint, during the class period, Activision Blizzard, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Activision Blizzard discriminated against women and minority employees; (2) Activision Blizzard fostered a pervasive "frat boy" workplace culture that continues to thrive; (3) numerous complaints about unlawful harassment,
discrimination, and retaliation were made to human resources personnel and executives which went unaddressed; (4) the pervasive culture of harassment, discrimination, and retaliation would result in serious impairments to Activision Blizzard's operations; (5) as a result of the foregoing, the Company was at greater risk of regulatory and legal scrutiny and enforcement, including that which would have a material adverse effect; (6) Activision Blizzard failed to inform shareholders that the California Department of Fair Employment and Housing had been investigating Activision Blizzard for harassment and discrimination; and (7) as a result, Defendants' statements about Activision Blizzard's business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
SOURCE: Levi & Korsinsky, LLP
View source version on accesswire.com:
https://www.accesswire.com/664775/CLASS-ACTION-UPDATE-for-OTLY-ARDX-and-ATVI-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders
